Abstracts tagged "Adalimumab and juvenile spondylarthropathy"

Abstract Number: 269 • 2014 ACR/ARHP Annual Meeting
Discontinuation of Concomitant Medication for Enthesitis-Related Arthritis during 52 Weeks of Treatment with Adalimumab
Shirley ML Tse¹, Rubén Burgos-Vargas², Gerd Horneff³, Aileen L. Pangan⁴, Jasmina Kalabic⁵, Kristina Unnebrink⁵ and Jaclyn K. Anderson⁴, ¹Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, ²Hospital General de Mexico, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico, ³Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, ⁴AbbVie Inc., North Chicago, IL, ⁵AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
Background/Purpose: Children with enthesitis-related arthritis (ERA) require medical therapy to control inflammation and restore normal function; however, the use of multiple medications and for longer…